Prenetics Global (PRE)
(Delayed Data from NSDQ)
$4.36 USD
0.00 (0.00%)
Updated Sep 20, 2024 03:29 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Balance Sheet
Fiscal Year End for Prenetics Global Limited falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 62 | 167 | 0 | -99,999 | -99,999 |
Receivables | 4 | 42 | 0 | NA | NA |
Notes Receivable | 0 | NA | 0 | NA | NA |
Inventories | 3 | 5 | 0 | NA | NA |
Other Current Assets | 25 | 29 | 1 | NA | NA |
Total Current Assets | 94 | 242 | 1 | NA | NA |
Net Property & Equipment | 6 | 13 | 0 | NA | NA |
Investments & Advances | 108 | NA | 339 | NA | NA |
Other Non-Current Assets | 0 | NA | 0 | NA | NA |
Deferred Charges | 4 | 7 | 0 | NA | NA |
Intangibles | 43 | 44 | 0 | NA | NA |
Deposits & Other Assets | 1 | 2 | 0 | NA | NA |
Total Assets | 254 | 308 | 340 | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | NA | 0 | NA | NA |
Accounts Payable | 2 | 7 | 0 | NA | NA |
Current Portion Long-Term Debt | 0 | NA | 0 | NA | NA |
Current Portion Capital Leases | 0 | NA | 0 | NA | NA |
Accrued Expenses | 8 | 16 | 3 | NA | NA |
Income Taxes Payable | 7 | 9 | 0 | NA | NA |
Other Current Liabilities | 21 | 23 | 0 | NA | NA |
Total Current Liabilities | 39 | 57 | 3 | NA | NA |
Mortgages | 0 | NA | 0 | NA | NA |
Deferred Taxes/Income | 3 | 2 | 12 | NA | NA |
Convertible Debt | 0 | NA | 0 | NA | NA |
Long-Term Debt | 0 | NA | 0 | NA | NA |
Non-Current Capital Leases | 0 | NA | 0 | NA | NA |
Other Non-Current Liabilities | 1 | 5 | 352 | NA | NA |
Minority Interest (Liabilities) | 0 | NA | 0 | NA | NA |
Total Liabilities | 44 | 68 | 367 | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | NA | 0 | NA | NA |
Common Stock (Par) | 0 | 0 | 0 | NA | NA |
Capital Surplus | 933 | NA | 0 | NA | NA |
Retained Earnings | -471 | 237 | -27 | NA | NA |
Other Equity | -252 | 3 | 0 | NA | NA |
Treasury Stock | 0 | NA | 0 | NA | NA |
Total Shareholder's Equity | 210 | 240 | -27 | NA | NA |
Total Liabilities & Shareholder's Equity | 254 | 308 | 340 | NA | NA |
Total Common Equity | 210 | 100,239 | -27 | 0 | 0 |
Shares Outstanding | 9.10 | 9.10 | 2.90 | NA | NA |
Book Value Per Share | 23.09 | 11,015.28 | -9.33 | 0.00 | 0.00 |
Fiscal Year End for Prenetics Global Limited falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 55 | 62 | 71 | 177 |
Receivables | NA | 4 | 4 | 5 | 6 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 3 | 3 | 3 | 4 |
Other Current Assets | NA | 25 | 25 | 26 | 28 |
Total Current Assets | NA | 87 | 94 | 105 | 215 |
Net Property & Equipment | NA | 5 | 6 | 9 | 10 |
Investments & Advances | NA | 108 | 108 | 109 | 1 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 2 | 4 | 5 | 7 |
Intangibles | NA | 42 | 43 | 47 | 48 |
Deposits & Other Assets | NA | 1 | 1 | 1 | 1 |
Total Assets | NA | 244 | 254 | 276 | 281 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 2 | 4 | 4 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 7 | 8 | 8 | 19 |
Income Taxes Payable | NA | 7 | 7 | 9 | 9 |
Other Current Liabilities | NA | 20 | 21 | 18 | 17 |
Total Current Liabilities | NA | 37 | 39 | 40 | 52 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 2 | 3 | 3 | 3 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 2 | 3 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 41 | 44 | 48 | 61 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 0 | 933 | 0 | 0 |
Retained Earnings | NA | 0 | -471 | 0 | 0 |
Other Equity | NA | 203 | -252 | 229 | 220 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 203 | 210 | 229 | 220 |
Total Liabilities & Shareholder's Equity | NA | 244 | 254 | 276 | 281 |
Total Common Equity | 0 | 203 | 210 | 229 | 220 |
Shares Outstanding | 9.10 | 9.10 | 9.10 | 9.10 | 9.10 |
Book Value Per Share | 0.00 | 22.28 | 23.09 | 25.14 | 24.20 |